MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41467-022-31210-w

Медицинская библиотека · Nature communications · 2022

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.

Shaqra Ala M, Zvornicanin Sarah N, Huang Qiu Yu J, Lockbaum Gordon J, Knapp Mark, Tandeske Laura, Bakan David T, Flynn Julia, Bolon Daniel N A, Moquin Stephanie, Dovala Dustin, Kurt Yilmaz Nese, Schiffer Celia A

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Coronaviruses can evolve and spread rapidly to cause severe disease morbidity and mortality, as exemplified by SARS-CoV-2 variants of the COVID-19 pandemic. Although currently available vaccines remain mostly effective against SARS-CoV-2 variants, additional treatment strategies are needed. Inhibitors that target essential viral enzymes, such as proteases and polymerases, represent key classes of antivirals. However, clinical use of antiviral therapies inevitably leads to emergence of drug resistance. In this study we implemented a strategy to pre-emptively address drug resistance to protease inhibitors targeting the main protease (Mpro) of SARS-CoV-2, an essential enzyme that promotes viral maturation. We solved nine high-resolution cocrystal structures of SARS-CoV-2 Mpro bound to substrate peptides and six structures with cleavage products. These structures enabled us to define the substrate envelope of Mpro, map the critical recognition elements, and identify evolutionarily vulnerable sites that may be susceptible to resistance mutations that would compromise binding of the newly developed Mpro inhibitors. Our results suggest strategies for developing robust inhibitors against SARS-CoV-2 that will retain longer-lasting efficacy against this evolving viral pathogen.

Для цитирования: Shaqra Ala M, Zvornicanin Sarah N, Huang Qiu Yu J, Lockbaum Gordon J, Knapp Mark, Tandeske Laura, Bakan David T, Flynn Julia, Bolon Daniel N A, Moquin Stephanie, Dovala Dustin, Kurt Yilmaz Nese, Schiffer Celia A. Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.. Nature communications. 2022. DOI: 10.1038/s41467-022-31210-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.